You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,925,844


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,925,844 protect, and when does it expire?

Patent 10,925,844 protects LUMRYZ and is included in one NDA.

This patent has twenty-nine patent family members in ten countries.

Summary for Patent: 10,925,844
Title:Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
Abstract:Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
Inventor(s):Grassot Julien, Grangeon Cendrine, Dubow Jordan
Assignee:Flamel Ireland Limited
Application Number:US16987510
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,925,844: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 10,925,844, titled "Gamma-hydroxybutyrate Compositions Having Improved Pharmacokinetics in the Fed State," and provide a detailed analysis of its scope, claims, and the broader patent landscape.

Patent Overview

Title and Assignees

United States Patent 10,925,844 is assigned to Flamel Ireland Ltd and pertains to gamma-hydroxybutyrate (GHB) compositions with enhanced pharmacokinetics, particularly in the fed state[5].

Priority Date and Grant Date

The priority date for this patent is March 1, 2019, indicating when the initial application was filed. The patent was granted on a later date, marking the official recognition of the invention.

Scope of the Patent

Invention Description

The patent describes compositions of gamma-hydroxybutyrate, a compound used in various medical applications, including the treatment of narcolepsy and cataplexy. The invention focuses on improving the pharmacokinetics of GHB when administered in the fed state, which is crucial for maintaining consistent therapeutic effects regardless of the patient's dietary status.

Technical Details

The patent outlines specific formulations and methods for preparing these compositions. This includes details on the types of excipients, the manufacturing process, and the resulting pharmacokinetic profiles. The improved pharmacokinetics ensure that the drug is absorbed and metabolized consistently, even when taken with food.

Claims Analysis

Independent and Dependent Claims

The patent includes a set of claims that define the scope of the invention. Independent claims stand alone and define the broadest aspects of the invention, while dependent claims build upon the independent claims and provide additional specificity.

  • Independent Claims: These typically describe the core elements of the invention, such as the composition itself, the method of preparation, and the specific improvements in pharmacokinetics.
  • Dependent Claims: These claims further detail the invention by specifying particular aspects, such as the types of excipients used, the dosage forms, and any specific manufacturing steps.

Claim Construction

Understanding the construction of these claims is essential for determining the patent's scope. Claim construction involves interpreting the language of the claims to identify the exact boundaries of what is protected. This process is critical in patent litigation and licensing agreements[4].

Patent Landscape

Prior Art and Related Patents

To understand the novelty and non-obviousness of the invention, it is necessary to review prior art and related patents. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can help identify prior art cited by various patent offices, ensuring that the invention is distinct from existing technologies[1].

Global Dossier and International Patents

The Global Dossier service provides access to file histories and related applications from participating IP offices, helping to identify similar patents filed globally. This is particularly important for understanding the international patent landscape and potential licensing or infringement issues[1].

Competitors and Market Impact

Analyzing the patent landscape also involves identifying competitors who may be working on similar technologies. This can be done by searching patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Economic and Legal Implications

Patent Monetization and Licensing

The patent can be monetized through licensing agreements, allowing other companies to use the patented technology. This is a common strategy for non-practicing entities (NPEs) and can be a significant revenue stream for the patent owner[4].

Patent Litigation

Understanding the claims and scope of the patent is crucial for avoiding or defending against patent infringement lawsuits. The exclusive rights granted by the patent can restrict competition, but they also provide a legal basis for enforcing these rights against infringers[4].

Practical Applications and Future Directions

Clinical Implications

The improved pharmacokinetics of GHB compositions can have significant clinical implications, such as enhanced therapeutic efficacy and reduced side effects. This can lead to better patient outcomes and increased market acceptance of the drug.

Research and Development

The patent's focus on formulation and pharmacokinetics opens avenues for further research and development. Future studies could explore additional excipients, dosage forms, or delivery mechanisms to further enhance the drug's performance.

Key Takeaways

  • Patent Scope: The patent protects specific compositions of gamma-hydroxybutyrate with improved pharmacokinetics in the fed state.
  • Claims Analysis: Understanding independent and dependent claims is crucial for defining the invention's boundaries.
  • Patent Landscape: Reviewing prior art and global patents helps in assessing the invention's novelty and potential market impact.
  • Economic and Legal Implications: The patent can be monetized through licensing and enforced through litigation to protect exclusive rights.
  • Practical Applications: The invention has significant clinical implications and potential for further research and development.

FAQs

Q: What is the primary focus of United States Patent 10,925,844?

A: The primary focus is on gamma-hydroxybutyrate compositions with improved pharmacokinetics, especially in the fed state.

Q: Who is the assignee of this patent?

A: The patent is assigned to Flamel Ireland Ltd.

Q: How can the scope of a patent be determined?

A: The scope of a patent is determined by analyzing its claims, both independent and dependent, and understanding the construction of these claims.

Q: What tools can be used to search for prior art and related patents?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) can be used to search for prior art and related patents.

Q: How can a patent be monetized?

A: A patent can be monetized through licensing agreements, allowing other companies to use the patented technology, and through enforcement in patent litigation.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Assessing Factors That Affect Patent Infringement Litigation ... - GAO: https://www.gao.gov/assets/gao-13-465.pdf
  5. US-20180193277-A1 - Unified Patents Portal: https://portal.unifiedpatents.com/patents/patent/US-20180193277-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,925,844

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-001 May 1, 2023 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-002 May 1, 2023 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-003 May 1, 2023 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-004 May 1, 2023 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,925,844

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 109376 ⤷  Subscribe
Australia 2017300845 ⤷  Subscribe
Australia 2020231916 ⤷  Subscribe
Australia 2023203055 ⤷  Subscribe
Brazil 112019000848 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.